Dr. Archana Sharma is a distinguished scholar and accomplished researcher in the field of medicinal chemistry and pharmaceutical sciences. She currently serves as an Assistant Professor at Delhi Pharmaceutical Sciences and Research University where she has been contributing since 2021 with a focus on innovative drug discovery approaches. Holding advanced qualifications including M. Pharm., Ph. D., and MBA, she brings a unique interdisciplinary perspective to her research and teaching. Her academic journey has been marked by a steadfast commitment to advancing pharmaceutical education and research in India, establishing herself as a rising leader in medicinal chemistry. Her expertise spans the synthesis and evaluation of novel therapeutic compounds with significant potential for clinical applications.
Dr. Sharma's groundbreaking research on thiazolidin-4-one derivatives has established her as a leading authority in the development of novel anticancer agents with her work demonstrating significant potential for addressing chemotherapy limitations. Her comprehensive review on synthetic strategies and structure-activity relationships of thiazolidin-4-one compounds has provided critical insights for developing multi-target enzyme inhibitors with enhanced therapeutic profiles. With over 4,600 citations according to Google Scholar, her scholarly contributions have substantially influenced the direction of medicinal chemistry research in India and globally. Her work on curcumin-related compounds further demonstrates her innovative approach to harnessing natural products for pharmaceutical development, addressing critical challenges in cancer treatment.
Beyond her laboratory achievements, Dr. Sharma plays a pivotal role in mentoring the next generation of pharmaceutical scientists through her teaching and research supervision at Delhi Pharmaceutical Sciences and Research University. Her collaborative research approach has fostered productive partnerships across multiple institutions as evidenced by her extensive co-authorship network in high-impact publications. Currently she is advancing research on novel thiazolidin-4-one clubbed triazole derivatives aiming to develop more effective therapeutic agents with improved selectivity and reduced side effects. Dr. Sharma's ongoing work continues to bridge the gap between theoretical medicinal chemistry and practical drug development positioning her as a key contributor to India's growing pharmaceutical research landscape with promising implications for global healthcare innovation.
